A Phase III, Multicenter, Randomized, Double-blind, Active-Controlled Study (Aripiprazole Tablets) to Evaluate the Efficacy and Safety of Brexpiprazole in the Treatment of Adults With Acute Schizophrenia
Latest Information Update: 15 Nov 2021
At a glance
- Drugs Brexpiprazole (Primary) ; Aripiprazole
- Indications Schizophrenia
- Focus Registrational; Therapeutic Use
- Sponsors Otsuka Beijing Research Institute
Most Recent Events
- 11 Nov 2021 Status changed from active, no longer recruiting to completed.
- 28 Jun 2021 Status changed from recruiting to active, no longer recruiting.
- 04 Aug 2020 Planned End Date changed from 1 Oct 2020 to 1 Oct 2021.